top of page
Search


COVID-19 to reshape R&D investments toward infectious diseases
Infectious diseases have been largely forgotten by Pharma R&D and investors, as chronic diseases, cancer and rare diseases gave better...

Laurent DECORY
Jan 4, 20211 min read
Â
Â
Â


Post Brexit, will UK MedTech take back control or align with key markets ?
While Brexit goal is officially to "take back control", UK MedTech may have to choose between aligning regulatory process with EU or US....

Laurent DECORY
Dec 13, 20201 min read
Â
Â
Â


Germany bets on its Biotechs and mRNA COVID-19 vaccines
After granting €252M to CureVac, the German government has awarded €375M to BioNTech. BioNtech announcement: https://lnkd.in/dKinEe4...

Laurent DECORY
Dec 12, 20201 min read
Â
Â
Â


GENFIT moves focus to promising NASH diagnostic
In a promising but risky NASH market, study shows GENFIT NIS4 easy test allows to identify patients who require treatment, without need...

Laurent DECORY
Dec 12, 20201 min read
Â
Â
Â


Biosimilars finally taking off in the US
Usage of Biosimilars has increased significantly in Europe, while usage in the US has been lagging behind. Now, Biosimilars are finally...

Laurent DECORY
Dec 12, 20201 min read
Â
Â
Â


UCB’s Bimekizumab to reshape psoriasis market
The $ 20+ billion Psoriasis treatment market has been dominated by AbbVie's Humira. But things might change soon. After beating J&J’s...

Laurent DECORY
Dec 12, 20201 min read
Â
Â
Â
bottom of page


